These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24241176)
1. Standardizing management of hepatocellular carcinoma in China: devising evidence-based clinical practice guidelines. Song P Biosci Trends; 2013 Oct; 7(5):250-2. PubMed ID: 24241176 [TBL] [Abstract][Full Text] [Related]
2. "Knowledge into action" Exploration of an appropriate approach for constructing evidence-based clinical practice guidelines for hepatocellular carcinoma. Song PP; Gao JJ; Kokudo N; Dong JH; Tang W Biosci Trends; 2012 Jun; 6(3):147-52. PubMed ID: 22890164 [TBL] [Abstract][Full Text] [Related]
3. Systematic evidence-based clinical practice guidelines are ushering in a new stage of standardized management of hepatocellular carcinoma in Japan. Song P; Tang W; Hasegawa K; Kokudo N Drug Discov Ther; 2014 Apr; 8(2):64-70. PubMed ID: 24815580 [TBL] [Abstract][Full Text] [Related]
4. Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Kudo M; Izumi N; Kokudo N; Matsui O; Sakamoto M; Nakashima O; Kojiro M; Makuuchi M; Dig Dis; 2011; 29(3):339-64. PubMed ID: 21829027 [TBL] [Abstract][Full Text] [Related]
5. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology. Kudo M; Okanoue T; Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177 [TBL] [Abstract][Full Text] [Related]
6. The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011. Song P; Tobe RG; Inagaki Y; Kokudo N; Hasegawa K; Sugawara Y; Tang W Liver Int; 2012 Aug; 32(7):1053-63. PubMed ID: 22432445 [TBL] [Abstract][Full Text] [Related]
7. Screening for and surveillance of high-risk patients with HBV-related chronic liver disease: promoting the early detection of hepatocellular carcinoma in China. Song P; Feng X; Zhang K; Song T; Ma K; Kokudo N; Dong J; Yao L; Tang W Biosci Trends; 2013 Feb; 7(1):1-6. PubMed ID: 23524887 [TBL] [Abstract][Full Text] [Related]
8. [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean Liver Cancer Study Group and National Cancer Center, Korea Korean J Hepatol; 2009 Sep; 15(3):391-423. PubMed ID: 19783891 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the current guidelines for resection of hepatocellular carcinoma using the Appraisal of Guidelines for Research and Evaluation II instrument. Gavriilidis P; Roberts KJ; Askari A; Sutcliffe RP; Huo TL; Liu PH; Hidalgo E; Compagnon P; Lim C; Azoulay D J Hepatol; 2017 Nov; 67(5):991-998. PubMed ID: 28690176 [TBL] [Abstract][Full Text] [Related]
10. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation. Song P; Tang W; Tamura S; Hasegawa K; Sugawara Y; Dong J; Kokudo N Biosci Trends; 2010 Dec; 4(6):283-7. PubMed ID: 21248425 [TBL] [Abstract][Full Text] [Related]
11. Demographic and clinical characteristics of resectable hepatocellular carcinoma in China and Japan. Yuan P; Tang W; Kokudo N; Hasegawa K; Xiang C; Li QM; Luo H; Wen J; Liang BH; Aoki T; Zhang KM; Sugawara Y; Imamura H; Sano K; Makuuchi M Hepatogastroenterology; 2007 Dec; 54(80):2343-7. PubMed ID: 18265661 [TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma: Western and Eastern surgeons' points of view. Vibert E; Ishizawa T J Visc Surg; 2012 Oct; 149(5):e302-6. PubMed ID: 22694943 [TBL] [Abstract][Full Text] [Related]
13. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma. Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858 [TBL] [Abstract][Full Text] [Related]
14. [Current status and prospect of liver transplantation for hepatocellular carcinoma]. Yan LN Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):427-30. PubMed ID: 16178432 [TBL] [Abstract][Full Text] [Related]
15. Ethical selection on liver transplantation and abandoning treatment for hepatocellular carcinoma in China. Xia D; Zuo HQ; Quan Y; Dong HL; Xu L Transplant Proc; 2011 Sep; 43(7):2656-9. PubMed ID: 21911141 [TBL] [Abstract][Full Text] [Related]
16. [Inspection of guidelines for hepatocellular carcinoma]. Arii S Gan To Kagaku Ryoho; 2010 Apr; 37(4):604-8. PubMed ID: 20414014 [TBL] [Abstract][Full Text] [Related]
17. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. Kokudo N; Makuuchi M J Gastroenterol; 2009; 44 Suppl 19():119-21. PubMed ID: 19148805 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of hepatitis virus infection in hepatocellular carcinoma patients receiving surgical operation in China and Japan]. Yuan P; Tang W; Wen J; Li QM; Luo H; Liang BH; Zheng QM; Wei L Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep; 39(5):332-4. PubMed ID: 16266545 [TBL] [Abstract][Full Text] [Related]
19. [Value of liver transplantation in hepatocellular carcinoma treatment]. Zheng SS; Wu J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):366-70. PubMed ID: 18795603 [TBL] [Abstract][Full Text] [Related]